companies developing glp-1 drugs Chinese Are Advanced Solving the Unmet Needs in

The retrieved data included study characteristics, characteristics of patients, interventions, and outcome measures, that included the hazard ratios (HR) and confidence intervals (CI) for cardiorenal outcomes

Ongoing and future largescale randomized trials will be critical for clarifying efficacy and safety for this use

Onceweekly dulaglutide versus oncedaily liraglutide in metformintreated patients with type 2 diabetes (AWARD6): a randomised, openlabel, phase 3, noninferiority trial

Mounjaro (tirzepatide) Mounjaro was approved for the treatment of type 2 diabetes in 2022, and its also often prescribed off-label for weight loss

The vasodilatory effects were not observed after denuding the endothelium from the rat coronary arteries, thus suggesting endothelium-dependent effects (Xiong et al., 2019)